Cetilistat (ATL -962), a novel lipase inhibitor: a 12 week randomised, placebo-controlled study of weight reduction in obese patients

Kopelman, PG, Bryson, A, Hickling, R, Rissanen, A, Rossner, S, Troubro, S and Valensi, P (2007) Cetilistat (ATL -962), a novel lipase inhibitor: a 12 week randomised, placebo-controlled study of weight reduction in obese patients. International Journal of Obesity, 31 (3). pp. 494-499.

Full text not available from this repository.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:10
Last Modified:	28 Feb 2011 12:51
URI:	https://ueaeprints.uea.ac.uk/id/eprint/13046
DOI:

Actions (login required)

View Item